Milestone Pharmaceuticals (MIST) announced that cardamyst nasal spray, its first commercial product, is now available through ...
CARDAMYST is now conveniently available to patients through retail pharmaciesNational sales force hired with promotional launch in mid-FebruaryExpected $25 copay cap for eligible commercially insured ...
GAITHERSBURG, Md., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement to obtain exclusive commercial rights in the U.S. and ...
Add Yahoo as a preferred source to see more of our stories on Google. AstraZeneca's FluMist was approved in 2003 to be given by health care providers. Last year, the FDA broadened the approval of the ...
Inclusion of neffy on Express Scripts commercial formularies was effective November 22, 2024 and expands access to patients and caregivers managing Type 1 Allergic Reactions SAN DIEGO, Dec. 19, 2024 ...
Milestone Pharmaceuticals announced a Commercial Launch Plan investor event, indicating proactive engagement with investors and transparency about its upcoming strategies. The event will detail the ...
The United States Patent and Trademark Office has issued U.S. Patent No. 12,514,854 B2, an Orange Book-listable patent ...
The changing of seasons is often accompanied by undesirable side effects known as seasonal allergies. Seasonal allergies plague many people due to the sudden presence of specific plant pollen that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results